Mekonos
We are a Silicon Valley chip technology startup aimed primarily toward cancer immunotherapy, gene engineering and drug development.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD136—205m (Dealroom.co estimates Nov 2021.)
San Francisco California (HQ)
Authorizing premium user...